IFI-M · UA Co-Expression Series

Specimen SS-F-M2-05439 // MULTI-AXIS · IFI-M

UA Co-Expression Series IV-AG-C

Solanum lycopersicum

Tomato

Tier IVUA Co-Expression Series

Target Trait

3.19×

fold-change

Umami+Astringency co-activation fold-change

Technical Specifications

SKU

SS-F-M2-05439

Genomic Edits

10

GC Content

47.4%

Construct Length

5,187 bp

Promoter System

Tissue-specific 2A11

Expression System

Agrobacterium-mediated T-DNA

Host Strain

EHA105

Receptor Target

mGluR1 + Polyphenol-astringency axis

IFI Score

319

Pathway Edits

  • mGluR1 pathway primary gene cluster overexpression for umami axis activation
  • Polyphenol-astringency axis pathway primary gene cluster overexpression for astringency axis activation
  • Bidirectional promoter system for synchronized U+A dual-axis co-expression
  • Metabolic flux partitioning between IFI-U and IFI-A pathway branches via carbon flow optimization
  • Transcription factor co-binding site engineering for Umami-Astringency combinatorial gene regulation
  • Cross-pathway feedback inhibition circuit removal for U+A simultaneous accumulation
  • Cofactor balance optimization for U+A dual-pathway operation
  • Protein scaffold engineering for U+A enzyme co-localization

Key Interventions

Dual-receptor co-activation via synchronized mGluR1 and Polyphenol-astringency axis pathway engineeringMetabolic flux partitioning strategy enabling simultaneous umami and astringency accumulation without competing pathway suppressionCo-expression vector design for UA multi-axis integrationT-DNA binary vector 2A11 for stable genomic integration of multi-axis construct stack

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier IV UA dual-axis co-expression platform for food ingredient applications requiring verified combined umami+astringency sensory character. Suitable for multi-modal flavor architecture, premium ingredient certification, and receptor-confirmed IFI multi-axis profiling.

License

$4149 · Tier IV License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-MAll Modalities